Department of Dermatology, Mayo Clinic School of Graduate Medical Education, Rochester, MN.
Department of Dermatology, Mayo Clinic School of Graduate Medical Education, Rochester, MN.
Mayo Clin Proc. 2023 May;98(5):713-722. doi: 10.1016/j.mayocp.2022.10.029.
To identify changes in the incidence and mortality of cutaneous melanoma in the fastest-growing segment of the US population, middle-aged adults.
Using the Rochester Epidemiology Project, patients aged 40 to 60 years with a first lifetime diagnosis of cutaneous melanoma between January 1, 1970, and December 31, 2020, while a resident of Olmsted County, Minnesota, were identified.
A total of 858 patients with a primary cutaneous first-time melanoma were identified. The overall age- and sex-adjusted incidence rate increased from 8.6 (95% CI, 3.9 to 13.3) per 100,000 person-years in 1970-1979 to 99.1 (95% CI, 89.5 to 108.7) per 100,000 person-years in 2011-2020 (11.6-fold increase). There was a 52.1-fold increase in women and a 6.3-fold increase in men between these 2 periods. In recent years (2005-2009 vs 2015-2020), the incidence has stabilized in men (1.01-fold increase; P=.96) and continues to significantly increase in women (1.5-fold increase; P=.002). Among 659 patients with invasive melanoma, 43 deaths were due to melanoma, and male sex was significantly associated with an increased risk of death (hazard ratio, 2.95; 95% CI, 1.45 to 6.00). A more recent diagnosis of melanoma was significantly associated with a decreased risk of death due to melanoma (hazard ratio, 0.66 per 5-year increase in calendar year of diagnosis; 95% CI, 0.59 to 0.75).
Melanoma incidence has significantly increased since 1970. During the past 15 years, the incidence has continued to rise in middle-aged women (approximately 50% rise in incidence) but has stabilized in men. Mortality decreased in a linear fashion throughout this time.
确定美国人口增长最快的年龄段——中年人群中皮肤黑色素瘤发病率和死亡率的变化。
利用罗切斯特流行病学项目,在明尼苏达州奥姆斯特德县居住的年龄在 40 岁至 60 岁之间的人群中,选取 1970 年 1 月 1 日至 2020 年 12 月 31 日期间首次诊断为皮肤黑色素瘤的患者。
共发现 858 例原发性皮肤黑色素瘤患者。年龄和性别调整后的发病率从 1970-1979 年的 8.6(95%置信区间,3.9 至 13.3)/100000 人年增加到 2011-2020 年的 99.1(95%置信区间,89.5 至 108.7)/100000 人年(增加 11.6 倍)。在此期间,女性增加了 52.1 倍,男性增加了 6.3 倍。在最近几年(2005-2009 年与 2015-2020 年),男性发病率趋于稳定(增加 1.01 倍;P=.96),而女性发病率仍显著增加(增加 1.5 倍;P=.002)。在 659 例侵袭性黑色素瘤患者中,有 43 例死于黑色素瘤,男性性别与死亡风险增加显著相关(风险比,2.95;95%置信区间,1.45 至 6.00)。较晚的黑色素瘤诊断与黑色素瘤死亡风险降低显著相关(风险比,每增加 5 年日历年份诊断风险降低 0.66;95%置信区间,0.59 至 0.75)。
自 1970 年以来,黑色素瘤发病率显著增加。在过去的 15 年中,中年女性的发病率持续上升(发病率上升约 50%),而男性的发病率则趋于稳定。在此期间,死亡率呈线性下降。